Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny - PubMed (original) (raw)
Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny
M Oren et al. Mol Cell Biol. 1982 Apr.
Abstract
F9 embryonal carcinoma cells express high levels of a 53,000-molecular-weight cellular tumor antigen called p53. When F9 cell cultures are treated with retinoic acid and dibutyryl adenosine 3',5'-phosphate, they differentiate, predominantly into endoderm-like cells. This differentiation is accompanied by a marked decrease in the levels of p53. The mechanism(s) responsible for this decline in the level of p53 in differentiated cells was investigated. The results demonstrate that the high levels of p53 in F9 cells relative to their differentiated progeny were not due to alterations in the stability or turnover of this protein. Rather, the regulation during differentiation involved a marked decrease in the amount of in vitro translatable p53 mRNA detected in the differentiated cell cultures. This mechanism is unlike the one operating during the simian virus 40 infection or transformation, where the increased levels of p53 are largely due to the increased stability of the p53 protein.
Similar articles
- Molecular analysis of early growth-associated events during the differentiation of F9 cells into embryoid bodies.
Whitman MM, Shen YM, Soprano D, Soprano KJ. Whitman MM, et al. Cancer Res. 1990 Jun 1;50(11):3193-8. Cancer Res. 1990. PMID: 2139801 - Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53.
Reich NC, Oren M, Levine AJ. Reich NC, et al. Mol Cell Biol. 1983 Dec;3(12):2143-50. doi: 10.1128/mcb.3.12.2143-2150.1983. Mol Cell Biol. 1983. PMID: 6318085 Free PMC article. - Lack of correlation between loss of anchorage-independent growth and levels of transformation-specific p53 protein in retinoic acid-treated F9 embryonal carcinoma cells.
Rodrigues M, Balicki D, Newrock KM, Mukherjee BB. Rodrigues M, et al. Exp Cell Res. 1985 Jan;156(1):22-30. doi: 10.1016/0014-4827(85)90258-7. Exp Cell Res. 1985. PMID: 2981174 - Post-transcriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9.
Dony C, Kessel M, Gruss P. Dony C, et al. Nature. 1985 Oct 17-23;317(6038):636-9. doi: 10.1038/317636a0. Nature. 1985. PMID: 2414665 - The regulation of a cellular protein, p53, in normal and transformed cells.
Levine AJ, Reich N, Thomas R. Levine AJ, et al. Prog Clin Biol Res. 1983;119:159-69. Prog Clin Biol Res. 1983. PMID: 6306685 Review. No abstract available.
Cited by
- The many faces of p53: something for everyone.
Levine AJ. Levine AJ. J Mol Cell Biol. 2019 Jul 19;11(7):524-530. doi: 10.1093/jmcb/mjz026. J Mol Cell Biol. 2019. PMID: 30925588 Free PMC article. Review. No abstract available. - Lysine methylation represses p53 activity in teratocarcinoma cancer cells.
Zhu J, Dou Z, Sammons MA, Levine AJ, Berger SL. Zhu J, et al. Proc Natl Acad Sci U S A. 2016 Aug 30;113(35):9822-7. doi: 10.1073/pnas.1610387113. Epub 2016 Aug 17. Proc Natl Acad Sci U S A. 2016. PMID: 27535933 Free PMC article. - p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome.
Spike BT, Wahl GM. Spike BT, et al. Genes Cancer. 2011 Apr;2(4):404-19. doi: 10.1177/1947601911410224. Genes Cancer. 2011. PMID: 21779509 Free PMC article. - Linking incomplete reprogramming to the improved pluripotency of murine embryonal carcinoma cell-derived pluripotent stem cells.
Chang G, Miao YL, Zhang Y, Liu S, Kou Z, Ding J, Chen DY, Sun QY, Gao S. Chang G, et al. PLoS One. 2010 Apr 26;5(4):e10320. doi: 10.1371/journal.pone.0010320. PLoS One. 2010. PMID: 20436676 Free PMC article. - The cancer treatment revolution.
Nathan DG. Nathan DG. Trans Am Clin Climatol Assoc. 2007;118:317-23. Trans Am Clin Climatol Assoc. 2007. PMID: 18528513 Free PMC article. No abstract available.
References
- Proc Natl Acad Sci U S A. 1973 Dec;70(12):3899-903 - PubMed
- Eur J Biochem. 1976 AUG 1;67(1):247-56 - PubMed
- Cell. 1978 Oct;15(2):393-403 - PubMed
- Nature. 1979 Mar 15;278(5701):261-3 - PubMed
- Proc Natl Acad Sci U S A. 1979 May;76(5):2420-4 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous